Community Connection: Ovarian Cancer Canada is looking for volunteers! Could you help?
OVdialogue – consider joining our team in the role of Community Champion. Over a few hours each week, you would be part of a team that helps connect people, support conversations and are thought leaders for OVdialogue. This is your opportunity to give back to those who have/continue to support you through the tough times, share your unique experiences, and help celebrate successes. For more details of what this entails, please reach out to @Mfallis (mfallis@ovariancanada.org).
OVdialogue – consider joining our team in the role of Community Champion. Over a few hours each week, you would be part of a team that helps connect people, support conversations and are thought leaders for OVdialogue. This is your opportunity to give back to those who have/continue to support you through the tough times, share your unique experiences, and help celebrate successes. For more details of what this entails, please reach out to @Mfallis (mfallis@ovariancanada.org).
Ovarian Cancer Canada is thrilled to share that we have some exciting updates on the way for OVdialogue. These enhancements are designed to strengthen our community and make your experience even better.
Stay tuned for more details, and feel free to share your thoughts below. Let’s make this community even stronger!
Stay tuned for more details, and feel free to share your thoughts below. Let’s make this community even stronger!
Desktop 3 Study
Comments
-
Hope this helps @Lucy22 as a stop gap. Highly suggest the questions better posed to your oncologist though. He or she is best to provide the information and explain any applicability or not to your condition.
Progression-free survival (PFS), the time from treatment initiation until disease progression or worsening, may be used as a direct or surrogate measure of clinical benefit for drug approvals, depending on the disease and response observed, while overall survival (OS), the duration of patient survival from the time of treatment initiation, is a universally-accepted direct measure of clinical benefit.
There is lots of information on the study if you google Desktop 3 study. If you're having trouble interpreting the information then again, I suggest your cancer care team can best provide the answers to your questions. Our group are survivors and, while we can share our own experiences with the disease and treatments, we're really not qualified to be dispensing medical information or interpretation.
You can also reach out directly to Tracy Kolwich at OCC who oversights OVd. She may be able to reach out to the OCC medical consultants for the information you're requesting. tkolwich@ovariancancer.org or @TracyOCC0
